The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Genomic Medicine
PreviousPrevious
Volume 348:919-932 March 6, 2003 Number 10
NextNext

Hereditary Colorectal Cancer
Henry T. Lynch, M.D., and Albert de la Chapelle, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
The annual incidence of colorectal cancer in the United States is approximately 148,300 (affecting 72,600 males and 75,700 females), with 56,600 deaths (in 27,800 males and 28,800 females).1 The lifetime risk of colorectal cancer in the general population is about 5 to 6 percent.1 Patients with a familial risk — those who have two or more first- or second-degree relatives (or both) with colorectal cancer — make up approximately 20 percent of all patients with colorectal cancer, whereas approximately 5 to 10 percent of the total annual burden of colorectal cancer is mendelian in nature — that is, it is . . . [Full Text of this Article]

Overall Clinical Approach

Diagnostic Clues

Familial Adenomatous Polyposis

Clinical and Molecular Features

Genetic Testing

Chemoprevention

Hereditary Nonpolyposis Colorectal Cancer

Clinical Features

Pathological Features

Accelerated Carcinogenesis

Features of Pedigrees

Incidence and Molecular Screening

Genes and Germ-Line Mutations

Assessing the Pathogenicity of Mutations

Sources of Underdiagnosis

Surveillance for Cancer

Efficacy of Surveillance

Somatic Mutations and the Progression to Cancer

Role of Epigenetics

Hamartomatous Polyposis Syndromes

Prospects for Prevention and Treatment


Source Information

From the Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, Nebr. (H.T.L.); and the Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University, Columbus (A.C.).

Address reprint requests to Dr. Lynch at the Department of Preventive Medicine and Public Health, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, or at htlynch@creighton.edu.


Related Letters:

Genetics of Colorectal Cancer
Chan W. M., Pang C. P., Lam D. S.C., Gripp K. W.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:2361-2362, Jun 5, 2003. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.